Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Obesity Drugs May Need Heart Risk Studies Before Approval
Obesity Drugs May Need Heart Risk Studies Before Approval
Obesity Drugs May Need Heart Risk Studies Before Approval
Submitted by
admin
on March 26, 2012 - 12:22pm
Source:
Bloomberg
News Tags:
obesity
Vivus
Arena Pharmaceuticals
Orexigen
Qnexa
Headline:
Obesity Drugs May Need Heart Risk Studies Before Approval
Do Not Allow Advertisers to Use My Personal information
